Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 22978290)

1.

Inhalable microparticles containing nitric oxide donors: saying NO to intracellular Mycobacterium tuberculosis.

Verma RK, Singh AK, Mohan M, Agrawal AK, Verma PR, Gupta A, Misra A.

Mol Pharm. 2012 Nov 5;9(11):3183-9. doi: 10.1021/mp300269g. Epub 2012 Sep 27.

PMID:
22978290
2.

Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.

Verma RK, Agrawal AK, Singh AK, Mohan M, Gupta A, Gupta P, Gupta UD, Misra A.

Tuberculosis (Edinb). 2013 Jul;93(4):412-7. doi: 10.1016/j.tube.2013.02.012. Epub 2013 Apr 3.

PMID:
23562366
3.

HLA-DRB1*1501 and VDR polymorphisms and survival of Mycobacterium tuberculosis in human macrophages exposed to inhalable microparticles.

Singh AK, Abhimanyu, Yadav AB, Sharma S, Garg R, Bose M, Misra A.

Pharmacogenomics. 2013 Apr;14(5):531-40. doi: 10.2217/pgs.13.12.

PMID:
23556450
4.

Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis.

Yadav AB, Muttil P, Singh AK, Verma RK, Mohan M, Agrawal AK, Verma AS, Sinha SK, Misra A.

Tuberculosis (Edinb). 2010 May;90(3):188-96. doi: 10.1016/j.tube.2010.03.001. Epub 2010 Apr 9.

PMID:
20382085
5.

Inhalable particles containing rapamycin for induction of autophagy in macrophages infected with Mycobacterium tuberculosis.

Gupta A, Pant G, Mitra K, Madan J, Chourasia MK, Misra A.

Mol Pharm. 2014 Apr 7;11(4):1201-7. doi: 10.1021/mp4006563. Epub 2014 Feb 24.

PMID:
24533458
6.

Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra.

Sharma R, Muttil P, Yadav AB, Rath SK, Bajpai VK, Mani U, Misra A.

J Antimicrob Chemother. 2007 Mar;59(3):499-506. Epub 2007 Jan 22.

7.

Inhalable microparticles containing isoniazid and rifabutin target macrophages and 'stimulate the phagocyte' to achieve high efficacy.

Yadav AB, Sharma R, Muttil P, Singh AK, Verma RK, Mohan M, Patel SK, Misra A.

Indian J Exp Biol. 2009 Jun;47(6):469-74.

PMID:
19634713
8.

Inhalable microparticles containing large payload of anti-tuberculosis drugs.

Muttil P, Kaur J, Kumar K, Yadav AB, Sharma R, Misra A.

Eur J Pharm Sci. 2007 Oct;32(2):140-50. Epub 2007 Jul 4. Erratum in: Eur J Pharm Sci. 2008 Aug 7;34(4-5):351.

PMID:
17681458
10.

Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines.

Wang C, Muttil P, Lu D, Beltran-Torres AA, Garcia-Contreras L, Hickey AJ.

AAPS J. 2009 Mar;11(1):139-47. doi: 10.1208/s12248-009-9089-0. Epub 2009 Mar 10.

11.
12.

Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model.

Suarez S, O'Hara P, Kazantseva M, Newcomer CE, Hopfer R, McMurray DN, Hickey AJ.

Pharm Res. 2001 Sep;18(9):1315-9.

PMID:
11683246
13.

Therapeutic aerosol bioengineering of targeted, inhalable microparticle formulations to treat Mycobacterium tuberculosis (MTb).

Lawlor C, O'Sullivan MP, Rice B, Dillon P, Gallagher PJ, O'Leary S, Shoyele S, Keane J, Cryan SA.

J Mater Sci Mater Med. 2012 Jan;23(1):89-98. doi: 10.1007/s10856-011-4511-4. Epub 2011 Dec 20.

PMID:
22183789
14.

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.

Pandey R, Sharma A, Zahoor A, Sharma S, Khuller GK, Prasad B.

J Antimicrob Chemother. 2003 Dec;52(6):981-6. Epub 2003 Nov 12.

15.

Development of a spray-drying method for the formulation of respirable microparticles containing ofloxacin-palladium complex.

Palazzo F, Giovagnoli S, Schoubben A, Blasi P, Rossi C, Ricci M.

Int J Pharm. 2013 Jan 20;440(2):273-82. doi: 10.1016/j.ijpharm.2012.05.045. Epub 2012 May 29.

PMID:
22659124
16.

PLGA microparticles in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen TB10.4-Ag85B.

Shi S, Hickey AJ.

Pharm Res. 2010 Feb;27(2):350-60. doi: 10.1007/s11095-009-0028-7. Epub 2009 Dec 19.

PMID:
20024670
17.

One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.

Ohashi K, Kabasawa T, Ozeki T, Okada H.

J Control Release. 2009 Apr 2;135(1):19-24. doi: 10.1016/j.jconrel.2008.11.027. Epub 2008 Dec 7.

PMID:
19121349
18.

Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis.

Hirota K, Hasegawa T, Nakajima T, Inagawa H, Kohchi C, Soma G, Makino K, Terada H.

J Control Release. 2010 Mar 19;142(3):339-46. doi: 10.1016/j.jconrel.2009.11.020. Epub 2009 Nov 29.

PMID:
19951729
19.

Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability.

Santucci MB, Amicosante M, Cicconi R, Montesano C, Casarini M, Giosuè S, Bisetti A, Colizzi V, Fraziano M.

J Infect Dis. 2000 Apr;181(4):1506-9. Epub 2000 Apr 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk